A note from Debra

Duchenne Community: Let Your Voice Be Heard!

Posted on August 27, 2015 6:27 pm


This week the FDA accepted Sarepta Therapeutics’ New Drug Application for eteplirsen with priority review. This follows on the June FDA’s acceptance of BioMarin’s NDA for drisapersen, also with priority review.

The next step for both of these drugs is an FDA Advisory Committee meeting in November where both companies will demonstrate why these drugs should be approved. Duchenne families have the opportunity to participate in this meeting. In fact, it’s vital for us to rally around this pivotal event and make our voices heard.

CureDuchenne was the lead organization to support the development of drisapersen and, CureDuchenne, along with Children’s National Medical Center and Foundation to Eradicate Duchenne, provided crucial funding to Sarepta (then AVI) to enable the development of eteplirsen.  We are proud to be the catalyst for exon skipping and, like you, are hopeful for FDA approval of these drugs soon.

As you know, these drugs will only address 13% of those affected with Duchenne, and we still need drugs to address cardiac and other issues with this disease.  There is more work to be done. But first we need to tell the FDA that the Duchenne community wants drisapersen and eteplirsen.

There are many ways to communicate with the FDA. Please email me at debra@cureduchenne.org if you would like to part of this historic event.

CureDuchenne’s Early Funding Projects Take a Big Step Forward Today

Posted on June 29, 20153:58 pm

  FDA Accepts NDA for Drisapersen, the First-Ever Treatment for Duchenne Muscular Dystrophy to Reach this Milestone in the U.S., and Sarepta Therapeutics Completes NDA Submission to FDA for Eteplirsen  It is a big day for the Duchenne community.  It is also a proud moment for CureDuchenne.  Today, BioMarin announced that the U.S. Food and Read more »

CureDuchenne’s Debra Miller Wins OCBJ Women in Business Award

Posted on June 26, 20157:56 pm

  On behalf of team CureDuchenne, we are ecstatic to announce that our co-founder and our daily inspiration Debra Miller was presented with the esteemed Women in Business Award to honor her career in finding a cure for Duchenne muscular dystrophy. The Orange County Business Journal’s Women in Business Award is presented to five outstanding Read more »